Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete
scalp, including eyelashes and eyebrows, or even the entire body. The exact pathology is …

Introduction Alopecia areata (AA) is a chronic, autoimmune disease of hair loss, which can
significantly affect the emotional and psychological well-being of patients. A systematic …

Management options for moderate‐to‐severe alopecia areata (AA) are limited owing to a
lack of safe and effective treatments suitable for long‐term use. However, newer agents …

Alopecia areata (AA) is an autoimmune condition that affects up to 2% of the general
population. Currently available treatment options for AA are of limited efficacy and can be …

Introduction Although alopecia areata (AA) profoundly impacts patients' physical
appearance, emotional state, and daily activities, no treatment approved for AA currently …

Ritlecitinib, an orally available Janus kinase 3 and tyrosine kinase inhibitor being developed
for the treatment of alopecia areata (AA), is highly soluble across the physiological pH range …

REFERENCES 1. Fee JA, McGrady FP, Rosendahl C, Hart ND. Training primary care
physicians in dermoscopy for skin cancer detection: a scoping review. J Cancer Educ. 2020; …

Online resources play a vital role in patient education, yet the readability of alopecia areata-
related materials remained understudied. A thorough analysis of online alopecia areata …

Background Alopecia areata (AA) is an autoimmune condition that leads to patchy,
nonscarring hair loss. Its etiology remains unknown; the condition can be debilitating for …

Aim: To evaluate and compare the efficacy of platelet-rich plasma (PRP) therapy in alopecia
areata (AA) patients with normal and with elevated levels of anti-thyroglobulin antibodies …